Advisory Board

Formerly Director of Research and Development at Hoffmann-LaRoche’s Vitamin Division. During his tenure Dr. Suter established a global R&D organization with focus on biological, biotechnical and chemical technologies and on developing new ingredients for the food, pharma and feed industries. Previously, he has held various leadership positions in Roche’s pharma and vitamin divisions including VP, Chemical Operations, in the USA.

Extraordinarius of management at the University of St. Gallen.
Prof. Dr. Pümpin has eight years experience as manager, and three as CMO, at the Swiss affiliate of a US computer manufacturer. He also holds a habilitation in Marketing; has published several books in the area of strategic management; is an advisor for strategic business management; acts as a docent at international congresses; and is an administrative board member.

Mr. de Chadarevian is the founder and Lead Director of OphthalmoPharma Ltd. and a co-founder of Ikonisys Inc. and CambriaTech Holding SA. He serves on the advisory board of Syntek Capital AG and is a non-executive board member of Friends of San Patrignano, Inc., a charitable organization. In Italy he is a biotechnology advisor to Sviluppo Italia, a government agency dedicated to promoting Italian investment opportunities, and to Lay Line Genomics SpA, a biotechnology company.
Until April 1998, Mr. de Chadarevian was Managing Director of Special Projects at Alza International and the Vice President of Corporate Development for Corange London Limited, two pharmaceutical companies. Prior to 1992, he held positions at Pasfin Servizi Finanziara SpA, GEA Consulenza and Credit Suisse.
From 1998 to 2001, Gamil G. de Chadarevian served as Executive Vice President International of Antigenics Inc. (NASDAQ: AGEN). Mr. de Chadarevian received his degree from the University of Zurich in Switzerland.